SG10201909093XA - Mixed allergen compositions and methods for using the same - Google Patents
Mixed allergen compositions and methods for using the sameInfo
- Publication number
- SG10201909093XA SG10201909093XA SG10201909093XA SG10201909093XA SG 10201909093X A SG10201909093X A SG 10201909093XA SG 10201909093X A SG10201909093X A SG 10201909093XA SG 10201909093X A SG10201909093X A SG 10201909093XA
- Authority
- SG
- Singapore
- Prior art keywords
- allergen
- methods
- mixed allergen
- compositions
- allergen compositions
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562119014P | 2015-02-20 | 2015-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201909093XA true SG10201909093XA (en) | 2019-11-28 |
Family
ID=56689334
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706734SA SG11201706734SA (en) | 2015-02-20 | 2016-02-19 | Mixed allergen compositions and methods for using the same |
| SG10201909093X SG10201909093XA (en) | 2015-02-20 | 2016-02-19 | Mixed allergen compositions and methods for using the same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706734SA SG11201706734SA (en) | 2015-02-20 | 2016-02-19 | Mixed allergen compositions and methods for using the same |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US10064936B2 (pl) |
| EP (2) | EP3258962B1 (pl) |
| JP (3) | JP6859261B2 (pl) |
| KR (1) | KR20170117562A (pl) |
| CN (2) | CN114129720A (pl) |
| AU (2) | AU2016219793C1 (pl) |
| BR (1) | BR112017017894A2 (pl) |
| CA (1) | CA2977127A1 (pl) |
| DK (1) | DK3258962T3 (pl) |
| ES (1) | ES2937287T3 (pl) |
| FI (1) | FI3258962T3 (pl) |
| HK (1) | HK1247854A1 (pl) |
| HU (1) | HUE061576T2 (pl) |
| IL (1) | IL253976B1 (pl) |
| LT (1) | LT3258962T (pl) |
| MA (1) | MA41558B1 (pl) |
| MX (2) | MX2017010697A (pl) |
| PL (1) | PL3258962T3 (pl) |
| PT (1) | PT3258962T (pl) |
| RS (1) | RS63941B1 (pl) |
| SG (2) | SG11201706734SA (pl) |
| SI (1) | SI3258962T1 (pl) |
| WO (1) | WO2016134291A2 (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| PL3258962T3 (pl) | 2015-02-20 | 2023-04-24 | The Board Of Trustees Of The Leland Stanford Junior University | Mieszane kompozycje alergenów i sposoby ich stosowania |
| US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US20160263212A1 (en) * | 2015-02-23 | 2016-09-15 | Antera Therapeutics Inc. | Compositions and methods for tolerizing the immune system to allergens |
| US10856567B2 (en) | 2016-07-22 | 2020-12-08 | Kari Brown | Baby food products containing allergenic proteins and methods of delivering same |
| MX2019005925A (es) * | 2016-11-21 | 2019-11-12 | Before Brands Inc | Composiciones de alergenos liquidas y metodos para la preparacion de las mismas. |
| US10656145B2 (en) | 2016-12-09 | 2020-05-19 | General Mills, Inc. | Detection of allergens using surface-enhanced raman scattering |
| SG10201913846XA (en) * | 2017-01-13 | 2020-03-30 | Aimmune Therapeutics Inc | Methods of manufacture of nut flours and formulations for oral immunotherapy |
| FR3062797A1 (fr) * | 2017-02-10 | 2018-08-17 | Centre Hospitalier Et Universitaire De Clermont-Ferrand | Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide |
| US20180360951A1 (en) * | 2017-06-20 | 2018-12-20 | Evros Vassiliou | Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d |
| SG11202000419QA (en) * | 2017-07-18 | 2020-02-27 | Before Brands Inc | Methods for making mixed allergen compositions |
| EP3720432A4 (en) | 2017-12-06 | 2021-08-25 | Prollergy Corporation | COMPOSITION AND METHOD FOR MITIGATING AN ALLERGIC REACTION |
| CA3120763A1 (en) * | 2018-11-30 | 2020-06-04 | Alladapt Immunotherapeutics, Inc. | Methods for making mixed allergen compositions |
| WO2020128063A1 (en) * | 2018-12-21 | 2020-06-25 | Société des Produits Nestlé S.A. | Drinkable infant compositions |
| EP3914098A1 (en) | 2019-01-23 | 2021-12-01 | Before Brands, Inc. | Methods for making mixed allergen compositions |
| US20200236982A1 (en) * | 2019-01-28 | 2020-07-30 | Lil Mixins, Llc | Tree nut powder formulation |
| US11154082B2 (en) | 2019-06-13 | 2021-10-26 | Lil Mixins, Llc | Egg product for infants and babies and method of making same |
| US11324247B2 (en) | 2019-06-13 | 2022-05-10 | Lil Mixins, Llc | Food products for infants and babies and method of making same |
| US20240151702A1 (en) * | 2021-03-05 | 2024-05-09 | Societe Des Produits Nestle S.A. | Methods of making and assessing allergenic tree nut compositions |
| US11154081B1 (en) | 2021-03-16 | 2021-10-26 | Lil Mixins, Llc | Well cooked egg powder |
| US11439173B1 (en) | 2021-09-22 | 2022-09-13 | Lil Mixins, Llc | Low allergenicity well cooked food powder |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031199A (en) | 1972-12-11 | 1977-06-21 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Process for the production of allergen-containing extracts |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| GB9323483D0 (en) | 1993-11-13 | 1994-01-05 | Cerestar Holding Bv | Edible composition and a process for its preparation |
| AU1951201A (en) | 1999-12-06 | 2001-06-12 | Mount Sinai School Of Medicine Of The City University Of New York, The | Peptide antigens |
| US6716471B2 (en) | 2000-05-12 | 2004-04-06 | Sigmund Kramer | Peanut powder compositions and methods of making same |
| FR2822709B1 (fr) | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
| US20070292446A9 (en) | 2003-06-23 | 2007-12-20 | Biotech Tools S.A. | Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| US7595081B1 (en) | 2003-10-17 | 2009-09-29 | Bellar Willis F | Non-flour containing baked and related food compositions |
| US8491909B2 (en) | 2004-02-06 | 2013-07-23 | Greer Laboratories, Inc. | Methods and compositions for dosing of allergens |
| BRPI0710963A2 (pt) * | 2006-02-27 | 2012-02-28 | South Georgia Pecan Company | Composição alimentícia para animais que compreende casca de noz |
| EP1872792A1 (en) | 2006-06-29 | 2008-01-02 | Biotech Tools S.A. | A method for the production of hydrolyzed allergen |
| CN101646418B (zh) * | 2006-10-12 | 2013-07-17 | 昆士兰大学 | 调节免疫应答的组合物和方法 |
| US8709413B2 (en) | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
| US20100278880A1 (en) | 2008-01-02 | 2010-11-04 | Biotech Tools S.A. | Pharmaceutical formulation for allergen preparation |
| WO2009094717A2 (en) | 2008-02-01 | 2009-08-06 | Murdoch Childrens Research Institute | A method of inducing tolerance to an allergen |
| EP2140880B1 (en) | 2008-07-04 | 2012-11-14 | HAL Allergy Holding B.V. | Modification of allergens |
| US8802056B2 (en) | 2008-07-17 | 2014-08-12 | John Shea | Method for testing and treating delayed food allergies |
| JP5805363B2 (ja) | 2009-06-26 | 2015-11-04 | 和興フィルタテクノロジー株式会社 | 可溶性凝集体、免疫寛容誘導剤及びその製造方法 |
| CN102695427B (zh) * | 2009-08-18 | 2016-04-13 | 雀巢产品技术援助有限公司 | 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 |
| ES2534558T3 (es) * | 2009-09-07 | 2015-04-24 | Dbv Technologies | Método de tratamiento de la esofagitis eosinofílica |
| CN102048077A (zh) | 2009-10-30 | 2011-05-11 | 梁振 | 一种方便营养果丁豆花 |
| WO2011137420A1 (en) | 2010-04-30 | 2011-11-03 | Apellis Pharmaceuticals, Inc. | Methods, articles and kits for allergic desensitization via the oral mucosa |
| US9724271B2 (en) * | 2010-04-30 | 2017-08-08 | Allovate, Llc | Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system |
| GB201009368D0 (en) | 2010-06-04 | 2010-07-21 | Sana Pharma As | Dietary formulations |
| KR20130118884A (ko) | 2010-10-15 | 2013-10-30 | 알크-아벨로 에이/에스 | 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제 |
| GB201104537D0 (en) | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
| CN102986802A (zh) | 2012-12-11 | 2013-03-27 | 崔杰 | 一种花生核桃咸饼的制作方法 |
| US9492535B2 (en) | 2013-03-14 | 2016-11-15 | Aimmune Therapeutics, Inc. | Peanut formulations and uses thereof |
| EP3482771B1 (en) | 2013-03-14 | 2023-01-18 | Société des Produits Nestlé S.A. | Manufacture of peanut formulations for oral desensitization |
| CA2903345A1 (en) | 2013-03-19 | 2014-09-25 | Biotech Tools S.A. | Allergen preparation |
| WO2014195803A2 (en) | 2013-06-06 | 2014-12-11 | Anergis S.A. | Contiguous overlapping peptides for treatment of house dust mites allergy |
| EP3046633A4 (en) | 2013-09-19 | 2017-03-15 | Allovate, LLC | Toothpaste for delivering allergens to oral mucosa |
| EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
| WO2016033094A1 (en) | 2014-08-25 | 2016-03-03 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
| CN104273238A (zh) * | 2014-09-27 | 2015-01-14 | 合肥市凤落河豆制食品有限公司 | 一种芝麻酱干及其制备方法 |
| PL3258962T3 (pl) | 2015-02-20 | 2023-04-24 | The Board Of Trustees Of The Leland Stanford Junior University | Mieszane kompozycje alergenów i sposoby ich stosowania |
| US10149904B2 (en) * | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US11452774B2 (en) * | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10166286B2 (en) * | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US20160263212A1 (en) | 2015-02-23 | 2016-09-15 | Antera Therapeutics Inc. | Compositions and methods for tolerizing the immune system to allergens |
-
2016
- 2016-02-19 PL PL16753171.4T patent/PL3258962T3/pl unknown
- 2016-02-19 ES ES16753171T patent/ES2937287T3/es active Active
- 2016-02-19 CN CN202111381997.6A patent/CN114129720A/zh active Pending
- 2016-02-19 DK DK16753171.4T patent/DK3258962T3/da active
- 2016-02-19 SG SG11201706734SA patent/SG11201706734SA/en unknown
- 2016-02-19 SG SG10201909093X patent/SG10201909093XA/en unknown
- 2016-02-19 IL IL253976A patent/IL253976B1/en unknown
- 2016-02-19 CN CN201680017213.2A patent/CN107405394B/zh active Active
- 2016-02-19 RS RS20230085A patent/RS63941B1/sr unknown
- 2016-02-19 SI SI201631663T patent/SI3258962T1/sl unknown
- 2016-02-19 MA MA41558A patent/MA41558B1/fr unknown
- 2016-02-19 KR KR1020177026057A patent/KR20170117562A/ko not_active IP Right Cessation
- 2016-02-19 LT LTEPPCT/US2016/018731T patent/LT3258962T/lt unknown
- 2016-02-19 AU AU2016219793A patent/AU2016219793C1/en active Active
- 2016-02-19 PT PT167531714T patent/PT3258962T/pt unknown
- 2016-02-19 WO PCT/US2016/018731 patent/WO2016134291A2/en active Application Filing
- 2016-02-19 CA CA2977127A patent/CA2977127A1/en active Pending
- 2016-02-19 JP JP2017544020A patent/JP6859261B2/ja active Active
- 2016-02-19 FI FIEP16753171.4T patent/FI3258962T3/fi active
- 2016-02-19 BR BR112017017894A patent/BR112017017894A2/pt active Search and Examination
- 2016-02-19 EP EP16753171.4A patent/EP3258962B1/en active Active
- 2016-02-19 US US15/048,609 patent/US10064936B2/en active Active
- 2016-02-19 MX MX2017010697A patent/MX2017010697A/es unknown
- 2016-02-19 EP EP22204813.4A patent/EP4186521A1/en active Pending
- 2016-02-19 HU HUE16753171A patent/HUE061576T2/hu unknown
- 2016-11-09 US US15/347,260 patent/US9731003B2/en active Active
-
2017
- 2017-08-18 MX MX2022008663A patent/MX2022008663A/es unknown
-
2018
- 2018-05-25 US US15/989,741 patent/US20190038741A1/en not_active Abandoned
- 2018-06-07 HK HK18107460.6A patent/HK1247854A1/zh unknown
-
2020
- 2020-12-24 JP JP2020215128A patent/JP2021046445A/ja active Pending
-
2021
- 2021-07-23 US US17/384,628 patent/US20220133882A1/en active Pending
-
2022
- 2022-03-11 AU AU2022201699A patent/AU2022201699A1/en active Pending
- 2022-07-11 JP JP2022110965A patent/JP2022125346A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022008663A (es) | Composiciones alergenicas mixtas y metodos de uso de las mismas. | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| PH12017501611A1 (en) | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof | |
| WO2017095944A8 (en) | Methods and compositions relating to chondrisomes from blood products | |
| MX2017008813A (es) | Polvo de coleopteros. | |
| MX2018002017A (es) | Compuestos de anillo de imidazo[4,5-c] sustituido con guanidina. | |
| SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
| MX2017004838A (es) | Composiciones de interleucina-15 y usos de estas. | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
| EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
| MX2017008815A (es) | Composicion que contiene quitina y proteinas digeribles. | |
| PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
| MX2018004715A (es) | Composicion que comprende una mezcla de moleculas extraidas de chrysanthellum indicum, cynara scolymus y lycium barbarum y uso para que actue en el metabolismo de carbohidratos y/o grasas. | |
| MX2018004616A (es) | Cosmetica qie tiene bacterias probioticas. | |
| MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
| NZ753163A (en) | Liquid allergen compositions and methods for making the same | |
| MX2018008645A (es) | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| BR112019017393A2 (pt) | formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas | |
| GB201302343D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods for using the same | |
| MX2017010277A (es) | Cenicriviroc para el tratamiento de la fibrosis. | |
| MY188028A (en) | Sialylated glycoprotein compositions and uses thereof | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| PH12017501979A1 (en) | Pharmaceutical compound |